Omni Bio Announces First Infusion in Phase I/II Clinical Trial of Alpha-1 Antitrypsin in Recently Diagnosed Diabetic …

Published October 18, 2010

Omni Bio Announces First Infusion in Phase I/II Clinical Trial of Alpha-1 Antitrypsin in Recently Diagnosed Diabetic …
Treatment Commences at Barbara Davis Center for Childhood Diabetes at University of Colorado Denver Anschutz Medical Campus
Read more on Marketwire

Wellness center expands offerings
Move to SSB increases space provided Health awareness is now more accessible with the expansion of Health Education, a component of the Wellness Center. …
Read more on The UTD Mercury